The new issue of the Journal of the Association of Medical Microbiology and Infectious Disease Canada examines pragmatic approaches to infection control policy; statin prescribing for people living with HIV; #LymeDisease testing; and more: bit.ly/JAMMI11-3 @AMMICanada

Discover the new issue of JAMMI (11.3) for research on pragmatic approaches to #infectioncontrol policy; syphilis antibody testing; statin prescribing for people living with HIV; improvements to Lyme disease testing in Canada; and more: bit.ly/JAMMI11-3 @AMMICanada

The new issue of JAMMI (11.3) opens with a Paediatric ID Note by Joseph Vayalumkal of @UCalgaryPeds arguing for a more pragmatic approach to infection control policy that focuses on stewardship of additional precautions and #PPE. Read more: bit.ly/JAMMI11-3a @AMMICanada

The latest issue of JAMMI (11.2) opens with a Paediatric ID Note exploring the long-term immune and neurologic consequences of measles in infants and young children. Read more: bit.ly/jammi11-2a @AMMICanada @SchulichMedDent #MedicalResearch

The latest issue of JAMMI features new research on the immune & neurologic consequences of measles in young children; adherence to cervical screening in HIV-positive women; the accuracy of AI responses on infection control measures; and more: bit.ly/jammi11-2 @AMMICanada

The new issue of the JAMMI (11.1) examines flu and antiviral use for 2025–26, penicillin allergy labels, and a case where oral Candida masked tongue cancer. @AMMICanada #InfectiousDiseases #MedicalMicrobiology #biothreats #biodefence Discover more: bit.ly/JAMMI111

Read a new article in JAMMI 11.1 evaluating the treatment of a critically ill patient in Canada with pre-extensively drug-resistant tuberculosis, highlighting the challenges of accessing recommended drugs. Read the study online: bit.ly/JAMMI111i #MedicalMicrobiology

A new #AdvanceArticle in JAMMI examines Lactococcus garvieae, a rare fish-associated pathogen increasingly linked to serious infections like endocarditis, and why advanced diagnostic tools are needed to correctly identify it. Read the full article: bit.ly/JAMMI_aa6

New in JAMMI 11.1: Switching some antibiotics from IV to oral, when appropriate, could cut health care costs, reduce hospital resource use, and lower carbon emissions—without compromising care. @VCHhealthcare @AMMICanada #InfectiousDiseases Read the study: bit.ly/JAMMI111g

Now available through JAMMI #AdvanceAccess: a new article examining Vagococcus fluvialis as an emerging cause of infective endocarditis and whether its presence in blood cultures should raise clinical suspicion. Discover the findings: bit.ly/JAMMI_aa5 @AMMICanada

New #AdvanceAccess research from JAMMI examines the effectiveness of combining daptomycin and linezolid to treat serious Enterococcus bloodstream infections, where standard antibiotics can fall short. Read the full study: bit.ly/JAMMI_aa4 @UofT_DoM

A new study in JAMMI 11.1 identifies a dangerous strain of Klebsiella pneumoniae that can cause severe infections in healthy adults. Once treatable, it shows resistance to key antibiotics, raising global concern. @WCHRIUofA @LKSIoV @ahs_media Learn more: bit.ly/JAMMI111f

New #AdvanceAccess articles from JAMMI are available. Explore how advanced DNA sequencing tools are changing the way infectious diseases are diagnosed and treated, and what this means for real-world clinical outcomes. Learn more: bit.ly/JAMMI_aa3 @med_umontreal

The new issue of the Journal of the Association of Medical Microbiology and Infectious Disease Canada features new studies on how Canadian clinicians diagnose, treat, and prevent Clostridioides difficile infections. Learn more: bit.ly/JAMMI111 @AMMICanada @McGillMed

A new #AdvanceAccess study in JAMMI examines bacteriophage therapy as a treatment for chronic prosthetic joint infections where surgery and antibiotics have failed. Can phages disrupt biofilms and change outcomes? Explore the findings: bit.ly/JAMMI_aa2 @CalDomMed

Discover the latest issue of the Journal of the Association of Medical Microbiology and Infectious Disease Canada, featuring research on influenza use for 2025–26, antibiotic prescribing, serious bacterial infections, and more. @AMMICanada Read more: bit.ly/JAMMI111

Read a new #AdvanceAccess article from JAMMI exploring how a decision tree approach can guide implementation of parvovirus B19 and hepatitis A virus nucleic acid testing to qualify plasma for fractionation. Discover key insights: bit.ly/JAMMI_aa1 @CanadasLifeline

A new study in JAMMI 11.1 identifies a dangerous strain of Klebsiella pneumoniae that can cause severe infections in healthy adults. Once treatable, it shows resistance to key antibiotics, raising global concern. @WCHRIUofA @LKSIoV @ahs_media Learn more: bit.ly/JAMMI111f

The new issue of the Journal of the Association of Medical Microbiology and Infectious Disease Canada features new studies on how Canadian clinicians diagnose, treat, and prevent Clostridioides difficile infections. Learn more: bit.ly/JAMMI111 @AMMICanada @McGillMed

Discover the latest issue of the Journal of the Association of Medical Microbiology and Infectious Disease Canada, featuring research on influenza use for 2025–26, antibiotic prescribing, serious bacterial infections, and more. Read more: bit.ly/JAMMI111 @AMMICanada